Growing community of inventors

Boulder, CO, United States of America

Luisa Mestroni

Average Co-Inventor Count = 2.86

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Luisa MestroniDaewon Park (2 patents)Luisa MestroniMaurizio Prato (2 patents)Luisa MestroniCarlin Long (2 patents)Luisa MestroniBrisa Pena Castellanos (2 patents)Luisa MestroniMatthew R G Taylor (2 patents)Luisa MestroniSusanna Bosi (2 patents)Luisa MestroniGiada Cellot (0 patent)Luisa MestroniLorena Zentilin (0 patent)Luisa MestroniFrancesca Maria Toma (0 patent)Luisa MestroniValentina Martinelli (0 patent)Luisa MestroniJohn Caldwell (0 patent)Luisa MestroniLaura Ballerini (0 patent)Luisa MestroniLuisa Mestroni (4 patents)Daewon ParkDaewon Park (8 patents)Maurizio PratoMaurizio Prato (4 patents)Carlin LongCarlin Long (2 patents)Brisa Pena CastellanosBrisa Pena Castellanos (2 patents)Matthew R G TaylorMatthew R G Taylor (2 patents)Susanna BosiSusanna Bosi (2 patents)Giada CellotGiada Cellot (0 patent)Lorena ZentilinLorena Zentilin (0 patent)Francesca Maria TomaFrancesca Maria Toma (0 patent)Valentina MartinelliValentina Martinelli (0 patent)John CaldwellJohn Caldwell (0 patent)Laura BalleriniLaura Ballerini (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Colorado (4 from 1,380 patents)

2. University of Trieste (0 patent)

3. I.c.g.e.b. International Centre for Genetic Engineering and Biotechnology (0 patent)


4 patents:

1. 12012478 - Carbon nanotube-functionalized reverse thermal gel and methods of forming and using same

2. 11608407 - Carbon nanotube-functionalized reverse thermal gel and methods of forming and using same

3. 10258606 - Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy

4. 9062347 - Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/17/2025
Loading…